Attorneys
Fletcher Moore
Fletcher Moore is a seasoned litigator. He specializes in contingency-fee litigation for plaintiffs in securities, shareholder derivative, class action, and business fraud cases.
Fletcher routinely represents investors and business owners (minority or majority) to make books and records demands, file shareholder derivative complaints, oppose dispositive motions, negotiate business buyouts, and draft corporate governance reforms.
Fletcher has been extensively involved in shareholder derivative cases involving insider trading, related party transactions, federal law violations, accounting fraud, usurping corporate opportunities, minority shareholder oppression, and other corporate malfeasance.
Fletcher seeks the maximum possible amount for shareholders whether in the form of buyouts, disgorgement, reimbursement, returning funds to company coffers, or significant corporate governance reforms.
Fletcher is experienced in pre-trial, trial, and post-trial practice. He has first-chair trial experience and has advocated for clients before State and Federal Courts throughout the United States, as well as JAMS mediators.
Fletcher began practicing at the large international law firm Duane Morris LLP, where he worked on a diverse range of complex litigation. He has worked closely with in-house counsel, businesses, and individuals to create successful litigation strategies in matters involving investment recovery, corporate governance, contract disputes, unfair competition, and other commercial litigation.
Admissions
- Connecticut
- New York
- Pennsylvania
- U.S. District Court for the Eastern District of Pennsylvania
- U.S. District Court for the Southern District of New York
- U.S. District Court for the District of Connecticut
Education
- New York Law School, J.D.
- University of Connecticut, B.A.
Selected Publications
- Co-author, “Supreme Court Orders Ninth Circuit to Revisit Preemption Ruling Against Generic OTC Ibuprofen Manufacturer,” Duane Morris Alert; republished by Linex Systems; republished in Product Liability Law360
- Co-author, “Big Win for Drug Companies Under the New Jersey Product Liability Act,” Duane Morris Alert; republished by Linex Systems; republished in·Product Liability Law360
- Co-author, “Pennsylvania District Court Dismisses Class Action Against Pharmaceutical Giant Johnson & Johnson,” Duane Morris Alert; republished in Product Liability Law360
- Co-author, “U.S. Supreme Court Holds That State-Law-Based Failure-to-Warn Claims Are Federally Preempted Against Generic Drug Manufacturers,” Duane Morris Alert
- Co-author, “In Smith v. Bayer Corp., Supreme Court Breathes New Life into Repetitive State Court Class Actions,” Duane Morris Alert
- Co-author, “In Pennsylvania Products Liability Decisions, Pharmaceutical Manufacturers May Lose a Little, but Gain a Lot,” Health Lawyers Weekly by American Health Lawyers Association; Product Liability Law360 and HealthLaw360 by Portfolio Medi